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Abstract 
Objective: Maternal vitamin D levels in pregnancy may have implications for both the mother and 
foetus. Deficiency of vitamin D has been linked to several pregnancy complications and foetal 
skeletal health. Smoking has been associated with reduced serum levels of vitamin D metabolite 
25(OH)D.  
Design: A nested case-control study within the Finish Maternity Cohort, a population based cohort 
which includes first trimester sera from 98% of pregnancies in Finland since 1987. The selection 
consisted of women with uncomplicated pregnancies. We studied sera concentration of 25(OH)D in 
313 non-smoking and 46 self-reported smoking pregnant women. 
Setting: We hypothesize that pregnant smokers may have an increased risk of low 25(OH)D levels 
especially during winter months.  
Subjects:  A control group consisting of uncomplicated pregnancies from a non-published 
pregnancy complication study included 359 uncomplicated pregnancies. Individuals, who reported 
that they do not smoke were considered to be ‘non-smokers’ (N=313) and those, who reported 
continued smoking after the first trimester of pregnancy were considered to be ‘smokers’ (N=46).  
Results: Smokers had significantly lower levels of 25(OH)D irrespective of sampling time 
(p<0.0001). Furthermore, during the low sun-exposure season, only 14% of smokers met the 
guideline levels of 40 nmol/L for serum 25(OH)D in comparison with 31% of non-smokers. 
Conclusions: Expectant mothers who smoke have an increased risk of vitamin D deficiency during 
low sun exposure months in the Northern regions. Further studies are needed to assess the 
associated risks for maternal and foetal health as well as possible long-term implications for the 
infant. 
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Introduction 
 
Smoking is known to be associated with low bone mass and increased risks of fractures, one of the 
plausible mechanisms being depressed 25-Hydroxyvitamin D (25(OH)D) levels among smokers.  
Vitamin D is also a versatile modulator of the immune system with anti-inflammatory and anti-
oxidant properties (1). Pregnant women in Finland were studied from 1997-2004 and during this 
time, a significant increase of daily vitamin D intake from mean 6.2 to 8.9 µg was recorded (2). The 
higher level is below the recommended 10 µg daily intake.   
The adverse effects of tobacco on reproductive health and pregnancy is well established. Tobacco 
increase the risk of infertility both in women and men. Increased risk of pregnancy loss is also 
observed among smokers compared with non-smokers (3). Tobacco contains hundreds of harmful 
substances and well-known carcinogens. Nicotine itself is vasoconstrictor, neuroteratogen 
impacting cytotrophoblast proliferation and differentiation (4). Nicotine and carbon monoxide cross 
the placenta rapidly and with chronic exposure the levels in the foetal compartment exceeds those 
on the maternal side. Although, the exact mechanisms are unknown tobacco results in adverse 
pregnancy outcomes, the association between tobacco and increased risk of foetal mortality has 
been recognized for decades (3). Smoking is associated with low birth weight, preterm birth, 
placental abruption, still birth, sudden infant death syndrome and neurobehavioral effects such as 
attention deficit hyperactivity disorder. Maternal smoking has profound effects on pregnancy and 
the future health of the offspring throughout life. Low birth weight and intrauterine growth 
retardation is often followed by childhood obesity and metabolic changes leading to elevated blood 
pressure and even elevated risk of type II diabetes (4).  
In Denmark, Brot et al reported a 10% decrease of circulating levels of 25(OH)D in smoking 
perimenopausal women (5). Levels of 25(OH)D have been shown to decline in a dose-dependent 
manner, in correlation with increased pack years of smoking (6). During pregnancy, smoking 
appears to have a similar effect, the decline of maternal 25(OH)D being in the order of 10-15%. 
Maternal 25OHD levels in turn correlate with foetal concentrations and 25(OH)D is known to cross 
placentas in in vitro placental perfusion studies, whereas calcitriol does not cross the placenta (7). 
However, the transfer of 25(OH)D from maternal to the foetal compartment has very little effect on 
maternal 25(OH)D.  
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Vitamin D is involved in several bone homeostasis and immunoregulatory pathways where it has 
complex roles. Some studies suggest that prenatal exposure to vitamin D deficiency or lower than 
non-pregnant parathyroid hormone (PTH) levels affects neonatal outcomes, such as skeletal health, 
caries, and growth (8,9). In addition, vitamin D plays a role in the human immune system and its 
deficiency is suggested to be associated with a number of pregnancy complications such as pre-
eclampsia, small for gestational age infants, gestational diabetes mellitus, and recurrent pregnancy 
loss (10-14). However, in pregnant women with severe vitamin D deficiency and vitamin D-dependent 
rickets type I or type II, in the absence of vitamin D supplementation, no change is observed in their 
own health or for their infant’s skeletal health (15).  
This study sets out to evaluate the effect of smoking and season on maternal 25(OD)H levels in 
early pregnancies prior to pregnancy related haemodilution and profound metabolic changes. The 
cohort with non-smoking and smoking women was selected from uncomplicated pregnancies to rule 
out the effects of pregnancy complications on 25(OH)D levels. The cohort represents a population 
with low sun exposure.         
 
Methods 
We used a national population-based Finnish Medical Birth Register (FMBR) to identify smoking 
and non-smoking subjects and to investigate the effect of smoking during pregnancy on vitamin D 
levels (16).  
FMBRcontains data on demographics, pregnancy, and delivery characteristics as well as diagnoses 
on all live births or still births since 1987 delivered after pregnancy week 22 or weighing >500 g 
during the first post-natal week. When data from multiple pregnancies was available, the most 
recent was used as an index pregnancy. A control group consisting of women with uncomplicated 
pregnancies from a non-published pregnancy complication study included 359 uncomplicated 
pregnancies. Of these women, 46 were smokers and 313 non-smokers. Serum samples from first 
trimester were identified within the Finnish Maternity Cohort (FMC) by a unique personal 
identification code, which has been assigned to each resident of Finland. Selected serum samples 
were then analysed for vitamin D levels. 
The FMC of the Northern Finland Biobank Borealis was established in 1983 as a nationwide effort 
of National Institute for Health and Welfare, Finland and is comprised of 2 million serum samples 
collected during the first and early second trimester of pregnancy (5th to 95th percentile: months 2–
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4 of pregnancy) from over 950,000 women. The FMC covers more than 98% of pregnancies in 
Finland with archived prenatal serum specimens drawn for routine screening for congenital 
infections (HIV, Hepatitis B and syphilis). Following informed consent, the remaining serum 
samples (one sample of 1-3 mls for each pregnancy) are stored at -25oC in a protected biorepository 
at the Northern Finland Biobank Borealis in Oulu and are available for scientific research 
(www.esis.fi).   
25(OH)D was measured in the first-trimester serum sample available in the FMC using a 
chemiluminescence microparticle immunoassay (CMIA) using an Architect i2000SR automatic 
analyser (Abbott Diagnostics) according to the manufacturer’s instructions. The CMIA test of 
Abbott Diagnostics has previously been found to succeed best at assay of serum 25(OH)D 
compared to other available methods (17). Furthermore, storage time have been found to have no 
effect on 25(OH)D levels (18). Coefficients of variation derived from repeated quality control 
samples included in the assay with the study samples were calculated. In internal control samples 
with “high” 25(OH)D (>100 nmol/L) the CV=3.5%, “medium” 25(OH)D levels (~80 nmol/L) 
1.8%, and “low” 25(OH)D levels (<40 nmol/L), 3.0%. In blinded QC pairs where 25(OH)D levels 
were not known, the CV was 1.1%.  
The smoking status in this study is self-reported. Individuals, who reported that they do not smoke 
were considered to be ‘non-smokers’ (N=313) and those, who reported continued smoking after the 
first trimester of pregnancy were considered to be ‘smokers’ (N=46).  
Statistics 
Independent-samples t-test was used to assess the statistical departure of vitamin D levels in 
smokers’ sera from levels observed in controls, because BMI did not differ between groups (Table 
1) and no other data was available to be included as covariants. Vitamin D data was normally 
distributed according to Kolmogorov-Smirnov test in both smokers and non-smokers. According to 
the Shapiro-Wilk test, the non-smoker’s data was not normally distributed (p=0.003), but by 
observation of the data histograms and box plots, this was deemed to be due to two outliers (less 
than 1% of data) with extremely high levels of vitamin D, while the bulk of the data conformed well 
to the normal distribution. We are aware, that the sample sizes differ between smokers and non-
smokers, but homogeneity of these groups was verified by Levene’s statistical test and no 
heterogeneity of variance was discovered. In the subanalysis by season, the non-equal variances 
probability value was reported when the Levene’s test of homogeneity of variance indicated 
departure from equal variances. Statistical analyses were carried out in SPSS vs. 24 (IBM).  
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Results 
We have analysed the levels of vitamin D during first trimester of healthy pregnancies in a Finnish 
population. The clinical characteristics of the study population are described in Table 1.   
The mean vitamin D levels in first trimester are shown in Figure 1. The levels of vitamin D are 
significantly lower (p-value < 0.001) in smokers (mean = 32.1, SD = 14.6) than in non-smokers 
(mean = 41.6, SD = 19.5). Figure 1 is in corroboration of previously published data indicating the 
decreasing effect of smoking on vitamin D levels (6).  
The main findings were that the 25(OH)D levels of smokers in winter are 74% of the25(OH)D 
levels of non-smokers and 77% in summer. Figure 2 shows that the relationship between smoking 
and vitamin D is more pronounced in the winter months when exposure to sun is extremely low. 
This association is observed during summer months (P-value = 0.028) and winter months (P-value 
< 0.001). Within the groups, the 25(OH)D difference between summer and winter seasons were 
41% among smoking and 38% among non-smoking pregnant women.   
 
Discussion 
We have studied 25(OH)D levels in first trimester of pregnancy in a Finnish population according 
to the season of sampling. Among the smokers, only four women (14%) in winter and nine women 
(53%) in summer had 25(OH)D of 40 nmol/L or more in comparison to 55 women (31%) in winter 
and 106 women (78%) in summer among non-smokers. The recommended reference level for 
25(OH)D in Finland is 40-80 nmol/L. Vitamin D deficiency is common in Finland particularly 
during the winter months (19). In contrast, the US National Health and Nutrition Examination Survey 
(NHANES) reports that 7% are deficient at <30 nmol/L and 72% of American pregnant and 
lactating women have 25(OH)D levels of 50 nmol/L or more (20).  
25(OH)D with a half-life of 14-20 d is a long-lived plasma metabolite and has been considered a 
stable and reliable marker of vitamin D status (15). Although measurement is technically 
challenging, the evidence on the relative difference between non-smoking and smoking pregnant 
women is in the order of at least 25% independently of seasonal variability (p-value <0.001). The 
selection of normal pregnancies to this cohort excludes the bias brought about by pregnancy 
complications that may be associated with alterations in 25(OH)D concentrations. On the other 
hand, the proportion of individuals that regularly uses vitamin D supplements as part of their diet is 
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not known in the registry data used in this study (21).  While ethnicity of the study population is not 
recorded, the study population is considered homogenous as a representation of the fair Finnish 
general population. 
Although, the exact mechanisms are not known how tobacco results in the adverse effects on 
pregnancy, the association between tobacco and increased risk of foetal mortality has been 
recognized for decades (3). We do not know the exact mechanisms behind smoking and vitamin D 
deficiency, and even less is known how the exacerbated effect of smoking on 25(OH)D levels is 
mediated during pregnancy. In this registry based study, detailed and verified information on 
possible confounding factors were not available. However, our data supports, that in a susceptible 
woman, smoking during pregnancy may be a particular risk for pregnancy complications during 
winter months, because this group has the lowest vitamin D levels and therefore a highest risk of 
pregnancy complications. Further studies are needed to decipher the interaction between PTH, 
vitamin D, and maternal smoking in relation to neonatal outcomes. There is no evidence of smoking 
affecting individual PTH levels (22). Furthermore, unlike 25(OH)D, PTH does not cross the placenta 
(8).  Therefore, the possible adverse consequences of smoking during pregnancy in relation to 
calcium homeostasis are likely related to the exaggerated deficiency of vitamin D among the 
smoking mothers as observed in our data. Furthermore, these effects may be interrelated and may 
offer new options for early preventive measures.  
Conclusion 
The present study shows that smoking during pregnancy is associated with a 27 % decline in 
25(OH)D levels in first trimester.  Our results also indicate that seasonal variation in 25(OH)D 
levels is similar among smoking and non-smoking pregnant women in their first trimester of 
pregnancy. Taken together, these changes result in very low 25(OH)D levels among pregnant 
smokers especially in wintertime, since most of the smoking women are below the recommended 
reference limits. To what extent the compound effect of smoking and low sun exposure directs 
maternal and foetal outcome and later development and immunology of the child are still open 
questions. In addition, our study does not address whether being below the target area is more 
dangerous in early versus late pregnancy. This cohort needs to be expanded to address these issues 
in the future. 
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Table 1. Clinical characteristics of smoking and non-smoking pregnancies.  
 
 
non-smokers 
(N=313) 
smokers (N=46) p-value * 
  
 
mean (SD) 
Maternal age (y) 27.56 (3.80) 23.63 (3.74) <0.001 
BMI (N=111 vs N=8) 24.08 24.42 NS 
Primiparity (%) 2.24 34.78 <0.001 † 
Gestational age at delivery (days) 280.80 (7.86) 279.47 (9.31) NS 
Birth weight (kg) 3677.76 (484.01) 3471.85 (406.84) 0.001 
Birth height (cm) 50.70 (1.88) 50.06 (1.66) 0.001 
Male gender (%) 50.80 36.96 NS 
Month of sampling ‡ 6.48 (3.48) 5.20 (3.44) NS 
Year of sampling  2000 (5.83) 2000 (6.14) NS 
    
    
 
NS not significant, SD standard deviation, BMI body 
mass index 
* p<0.05 is considered statistically significant 
 † Mann-Whitney U test, t-test
 if not indicated 
‡ 1=January – 12=December 
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Figure legends 
 
Figure 1. Women who smoke (N=46) during pregnancy have significantly lower vitamin D levels in 
serum than non-smoking (N=313) women.  
 
Figure 2. Differences between smokers and non-smokers in vitamin D levels are particularly 
pronounced during the winter months (November to May), when sun light is limited in Finland. 
Smokers, winter  N=29; non-smokers, winter N=175; smokers, summer N=17; non-smokers, 
summer N=136. 
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